Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-21-000011 General Corporate
Debt relative to revenue 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
177.19% · OPTIONAL · VALID
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.43% · OPTIONAL · VALID
Operating cash generation 20th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-4.46% · OPTIONAL · VALID
Revenue growth 35th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-0.69% · CORE · VALID
Inventory pressure 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
74.81% · OPTIONAL · VALID
Gross margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
35.13% · CORE · VALID
Operating margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.25% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.66% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.56% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 44.26%
Current 177.19%
Delta 132.93% Capex Intensity Decreased
Previous 1.99%
Current 1.43%
Delta -0.56% Cash Generation Decreased
Previous 10.92%
Current -4.46%
Delta -15.38% Growth Increased
Previous -3.88%
Current -0.69%
Delta 3.19% Inventory Pressure Increased
Previous 17.93%
Current 74.81%
Delta 56.87% Margin Decreased
Previous 35.18%
Current 35.13%
Delta -0.05% Profitability Increased
Previous 12.08%
Current 14.25%
Delta 2.17% R And D Intensity Increased
Previous 3.13%
Current 3.66%
Delta 0.53% Sbc Intensity Decreased
Previous 0.60%
Current 0.56%
Delta -0.05% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.